Documents

A list of downloadable documents created during development.

Review proposal consultation

Lung cancer (non small cell, EGFR mutation positive) - afatinib: Equality impact assessment - guidance development

Lung cancer (non small cell, EGFR mutation positive) - afatinib: final scope

Lung cancer (non small cell, EGFR mutation positive) - afatinib: final matrix

Lung cancer (non small cell, EGFR mutation positive) - afatinib: response to consultee and commentator comments on the draft scope and provisional matrix

Lung cancer (non small cell, EGFR mutation positive) - afatinib: Equality Impact Assessment - scoping

Lung cancer (non small cell, EGFR mutation positive) - afatinib: provisional matrix - (pre referral)

Lung cancer (non small cell, EGFR mutation positive) - afatinib: draft scope - (pre referral)